Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 18 04:00PM ET
10.23
Dollar change
-0.61
Percentage change
-5.63
%
Index- P/E- EPS (ttm)-4.08 Insider Own19.05% Shs Outstand25.28M Perf Week-13.38%
Market Cap258.82M Forward P/E- EPS next Y-2.75 Insider Trans-0.41% Shs Float20.48M Perf Month-9.55%
Income-87.37M PEG- EPS next Q-1.03 Inst Own48.48% Short Float3.10% Perf Quarter-1.54%
Sales0.00M P/S- EPS this Y5.09% Inst Trans- Short Ratio4.31 Perf Half Y29.00%
Book/sh2.27 P/B4.51 EPS next Y26.95% ROA-71.39% Short Interest0.63M Perf Year123.64%
Cash/sh5.46 P/C1.87 EPS next 5Y1.74% ROE-138.76% 52W Range4.26 - 15.18 Perf YTD25.68%
Dividend Est.- P/FCF- EPS past 5Y24.76% ROI-73.33% 52W High-32.61% Beta0.56
Dividend TTM- Quick Ratio5.45 Sales past 5Y-45.06% Gross Margin- 52W Low140.14% ATR (14)0.69
Dividend Ex-Date- Current Ratio5.45 EPS Y/Y TTM11.24% Oper. Margin0.00% RSI (14)36.15 Volatility5.36% 5.94%
Employees73 Debt/Eq0.53 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price28.79
Option/ShortYes / Yes LT Debt/Eq0.52 EPS Q/Q-3.51% Payout- Rel Volume0.45 Prev Close10.84
Sales Surprise-100.00% EPS Surprise-66.83% Sales Q/Q- EarningsMar 14 AMC Avg Volume147.07K Price10.23
SMA20-11.56% SMA50-14.32% SMA2007.05% Trades Volume66,842 Change-5.63%
Date Action Analyst Rating Change Price Target Change
Nov-21-23Resumed BTIG Research Buy $27
Sep-27-23Initiated B. Riley Securities Buy $21
Jun-15-23Upgrade Mizuho Neutral → Buy $24 → $36
Sep-07-22Resumed Alliance Global Partners Buy $6
Apr-29-22Resumed Cantor Fitzgerald Overweight $6 → $5
Apr-14-22Initiated RBC Capital Mkts Outperform $5
Mar-09-22Initiated Truist Buy $6
Jul-01-21Initiated Alliance Global Partners Buy $6
May-24-21Upgrade BTIG Research Neutral → Buy $8
Jun-20-19Downgrade BTIG Research Buy → Neutral
Today 04:05PM
Apr-09-24 07:00AM
Apr-04-24 07:30AM
Mar-18-24 07:00AM
Mar-14-24 09:54PM
04:53PM Loading…
04:53PM
04:05PM
Mar-11-24 07:30AM
Mar-05-24 05:27PM
04:30PM
Feb-15-24 03:12AM
Feb-07-24 05:02PM
07:15AM
Jan-29-24 07:00AM
Jan-22-24 08:15AM
04:00PM Loading…
Jan-18-24 04:00PM
Jan-11-24 07:00AM
Jan-05-24 07:00AM
Dec-18-23 07:00AM
Dec-13-23 09:08AM
07:00AM
Dec-03-23 04:17PM
Nov-22-23 12:00PM
Nov-13-23 07:00AM
Nov-08-23 05:52PM
04:12PM
Nov-07-23 07:00AM
Nov-06-23 07:00AM
Oct-26-23 04:05PM
Oct-18-23 04:50PM
12:30PM Loading…
Oct-14-23 12:30PM
Oct-06-23 07:00AM
Sep-28-23 02:15PM
Sep-05-23 07:00AM
Sep-04-23 01:23PM
Aug-28-23 07:00AM
Aug-08-23 05:46PM
04:05PM
Jul-11-23 07:00AM
Jul-10-23 04:05PM
Jul-05-23 04:05PM
Jun-16-23 05:00AM
Jun-15-23 04:06PM
04:00PM
May-31-23 09:11AM
May-25-23 05:05PM
May-16-23 07:00AM
May-09-23 04:56PM
04:05PM
May-02-23 07:45AM
May-01-23 07:00AM
Apr-26-23 04:05PM
Apr-18-23 07:05AM
Apr-06-23 05:39PM
04:05PM
Mar-15-23 07:00AM
Mar-14-23 04:05PM
Feb-02-23 07:00AM
Jan-30-23 12:00PM
Jan-24-23 05:46PM
05:45PM
Jan-18-23 04:05PM
Jan-11-23 06:24AM
Dec-15-22 04:30PM
Nov-08-22 08:22AM
Nov-03-22 04:05PM
Oct-20-22 07:00AM
Oct-07-22 04:05PM
Oct-04-22 07:00AM
Sep-19-22 09:31AM
Aug-23-22 12:23PM
Aug-08-22 07:00AM
Jul-27-22 11:40AM
Jul-07-22 07:00AM
Jun-27-22 11:17AM
Jun-07-22 02:26PM
Jun-06-22 07:00AM
May-19-22 06:00PM
May-18-22 08:45AM
May-09-22 04:05PM
08:25AM
Apr-04-22 04:05PM
Mar-28-22 01:46PM
07:05AM
07:00AM
Mar-24-22 07:05AM
Mar-01-22 07:52AM
Feb-22-22 05:00AM
Feb-03-22 05:38PM
Jan-11-22 07:00AM
Jan-07-22 07:00AM
Jan-04-22 04:05PM
Nov-23-21 08:53AM
Nov-22-21 07:30AM
Nov-15-21 06:01AM
Nov-14-21 08:53AM
Nov-11-21 07:00AM
Nov-04-21 04:05PM
09:25AM
Oct-26-21 07:00AM
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Calkins DanielChief Financial OfficerApr 05 '24Sale10.876658,535Apr 08 04:30 PM
Calkins DanielChief Financial OfficerMar 25 '24Sale12.02253008,541Mar 27 04:30 PM
Calkins DanielChief Financial OfficerMar 20 '24Sale11.07556098,566Mar 21 04:31 PM
Stuglik Brian MDirectorMar 19 '24Sale10.382732,83489,640Mar 20 05:32 PM
Paterson DanPresident and CEOMar 19 '24Sale10.381821,88986,490Mar 20 05:34 PM
Gagnon Robert E.DirectorMar 19 '24Sale10.381301,34927,391Mar 20 05:36 PM
Stuglik Brian MDirectorMar 18 '24Sale10.715375,75189,913Mar 20 05:32 PM
Gagnon Robert E.DirectorMar 18 '24Sale10.712833,03127,521Mar 20 05:36 PM
Paterson DanPresident and CEOMar 18 '24Sale10.712442,61386,672Mar 20 05:34 PM
Gagnon Robert E.DirectorFeb 06 '24Sale13.709,204126,09527,804Feb 07 04:00 PM
Gagnon Robert E.DirectorJan 12 '24Sale10.959,204100,78437,008Jan 17 04:00 PM
Calkins DanielChief Financial OfficerJan 05 '24Sale8.506518,621Jan 09 04:03 PM
Calkins DanielChief Financial OfficerDec 26 '23Sale8.08252028,350Dec 28 04:04 PM
Calkins DanielChief Financial OfficerDec 20 '23Sale7.93574528,375Dec 21 04:01 PM
Stuglik Brian MDirectorDec 19 '23Sale7.732742,11890,450Dec 20 04:00 PM
Paterson DanPresident and CEODec 19 '23Sale7.731831,41586,916Dec 20 04:01 PM
Gagnon Robert E.DirectorDec 19 '23Sale7.731301,00546,212Dec 20 04:03 PM
Stuglik Brian MDirectorDec 18 '23Sale7.644873,72190,724Dec 20 04:00 PM
Gagnon Robert E.DirectorDec 18 '23Sale7.642842,17046,342Dec 20 04:03 PM
Paterson DanPresident and CEODec 18 '23Sale7.642441,86487,099Dec 20 04:01 PM
Calkins DanielVice President of FinanceOct 05 '23Sale7.305368,432Oct 10 04:31 PM
Calkins DanielVice President of FinanceSep 25 '23Sale9.40252358,437Sep 25 04:46 PM
Calkins DanielVice President of FinanceSep 21 '23Sale9.312322,1608,462Sep 25 04:46 PM
Stuglik Brian MDirectorSep 19 '23Sale9.842742,69691,211Sep 20 04:15 PM
Paterson DanPresident and CEOSep 19 '23Sale9.841831,80187,343Sep 20 04:15 PM
Gagnon Robert E.DirectorSep 19 '23Sale9.841301,27946,626Sep 20 04:15 PM
Stuglik Brian MDirectorSep 18 '23Sale9.914784,73791,485Sep 20 04:15 PM
Gagnon Robert E.DirectorSep 18 '23Sale9.912782,75546,756Sep 20 04:15 PM
Paterson DanPresident and CEOSep 18 '23Sale9.912402,37887,526Sep 20 04:15 PM
Calkins DanielVice President of FinanceJul 06 '23Sale8.025408,694Jul 10 04:05 PM
Calkins DanielVice President of FinanceJun 26 '23Sale8.17262128,422Jun 28 04:11 PM
Stuglik Brian MChief Executive OfficerJun 20 '23Sale10.302752,83291,963Jun 21 04:23 PM
Paterson DanPresident and COOJun 20 '23Sale10.301831,88537,766Jun 21 04:25 PM
Gagnon Robert E.DirectorJun 20 '23Sale10.301301,33947,034Jun 21 04:24 PM
Stuglik Brian MChief Executive OfficerJun 16 '23Sale9.924874,83192,238Jun 21 04:23 PM
Gagnon Robert E.DirectorJun 16 '23Sale9.922832,80747,164Jun 21 04:24 PM
Paterson DanPresident and COOJun 16 '23Sale9.922442,42037,949Jun 21 04:25 PM